INS and Parkinson disease: Furthermore, “Glucagon signalling pathway”, “Type II diabetes mellitus” and “Insulin secretion”, all identified here as shared citrullinome pathways, have been identified to be linked target pathways for treatment in neuroinflammation, including in PD [80].